Sonova Holding AG (SONVY)
64.26
-0.31
(-0.48%)
USD |
OTCM |
May 24, 15:59
Sonova Price: 64.26 for May 24, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 23, 2024 | 64.65 | 64.97 | 64.49 | 64.57 | 6558.00 |
May 22, 2024 | 63.42 | 63.77 | 63.42 | 63.45 | 4605.00 |
May 21, 2024 | 61.93 | 61.93 | 61.67 | 61.77 | 4579.00 |
May 20, 2024 | 63.21 | 64.96 | 63.21 | 63.42 | 7286.00 |
May 17, 2024 | 64.04 | 64.27 | 64.04 | 64.22 | 5051.00 |
May 16, 2024 | 65.94 | 65.97 | 65.43 | 65.48 | 12101.00 |
May 15, 2024 | 65.64 | 66.01 | 65.64 | 65.93 | 8643.00 |
May 14, 2024 | 62.63 | 63.26 | 62.39 | 63.26 | 16397.00 |
May 13, 2024 | 59.01 | 59.12 | 58.80 | 58.88 | 7917.00 |
May 10, 2024 | 59.70 | 59.72 | 59.51 | 59.72 | 7353.00 |
May 09, 2024 | 58.70 | 59.31 | 58.70 | 59.19 | 9828.00 |
May 08, 2024 | 58.93 | 58.93 | 58.65 | 58.71 | 6488.00 |
May 07, 2024 | 58.98 | 59.22 | 58.64 | 58.78 | 19357.00 |
May 06, 2024 | 57.58 | 58.13 | 57.58 | 57.96 | 16167.00 |
May 03, 2024 | 58.36 | 58.36 | 58.04 | 58.32 | 9378.00 |
May 02, 2024 | 56.60 | 57.27 | 56.60 | 57.13 | 12115.00 |
May 01, 2024 | 55.17 | 56.05 | 54.99 | 56.04 | 6315.00 |
Apr 30, 2024 | 55.76 | 55.88 | 55.42 | 55.42 | 12262.00 |
Apr 29, 2024 | 56.53 | 56.81 | 56.53 | 56.80 | 13322.00 |
Apr 26, 2024 | 56.11 | 56.49 | 56.08 | 56.35 | 10957.00 |
Apr 25, 2024 | 54.75 | 55.42 | 54.75 | 55.28 | 13429.00 |
Apr 24, 2024 | 56.05 | 56.05 | 55.73 | 55.91 | 10053.00 |
Apr 23, 2024 | 55.53 | 56.01 | 55.53 | 55.85 | 24433.00 |
Apr 22, 2024 | 55.24 | 55.91 | 55.24 | 55.76 | 11237.00 |
Apr 19, 2024 | 54.66 | 54.66 | 54.27 | 54.28 | 9097.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
29.48
Minimum
Mar 23 2020
87.61
Maximum
Nov 04 2021
56.33
Average
52.59
Median
Sep 01 2023
Price Benchmarks
AC Immune SA | 3.535 |
CRISPR Therapeutics AG | 55.25 |
Addex Therapeutics Ltd | 8.55 |
NLS Pharmaceutics Ltd | 0.1711 |
Molecular Partners AG | 3.81 |
Price Related Metrics
PE Ratio | 28.06 |
PS Ratio | 4.653 |
PEG Ratio | 14.71 |
Price to Book Value | 6.996 |
Price to Free Cash Flow | 26.97 |
Earnings Yield | 3.56% |
Market Cap | 19.15B |
PEGY Ratio | 8.042 |
Operating PE Ratio | 25.18 |
Normalized PE Ratio | 28.06 |